By selecting the 'Susbcribe & Save' option you are enrolling in an auto-renewing subscription of Zookal Study Premium. Cancel at anytime.
Auto-Renewal
Your Zookal Study Premium subscription will be renewed each month until you cancel. You consent to Zookal automatically charging your payment method on file $19.99 each month after 1st month free period until you cancel.
How to Cancel
You can cancel your subscription anytime by visiting Manage account page, clicking "Manage subscription" and completing the steps to cancel. Cancellations take effect at the end of the 1st month free period (if applicable) or at the end of the current billing cycle in which your request to cancel was received. Subscription fees are not refundable.
Zookal Study Premium Monthly Subscription Includes:
Ability to post up to ten (10) questions per month.
20% off your textbooks order and free standard shipping whenever you shop online at
textbooks.zookal.com.au
Unused monthly subscription benefits have no cash value, are not transferable, and expire at the end of each month. This means that subscription benefits do not roll over to or accumulate for use in subsequent months.
Payment Methods
Afterpay and Zip Pay will not be available for purchases with Zookal Study Premium subscription added to bag.
$1.00 preauthorisation
You may see a $1.00 preauthorisation by your bank which will disappear from your statement in a few business days..
Email communications
By adding Zookal Study Premium, you agree to receive email communications from Zookal.
This issue of Anesthesiology Clinics focuses on Pharmacology. Editor Alan Kaye has assembled an expert team of authors on topics such as: Ketorolac, Oxymorphone and Tapentadol; Anticoagulation and Neuraxial/Peripheral Anesthesia; Pharmacologic Update on Antiemetics: Total parenteral nutrition/enteral nutrition in the ICU, Evolving Concepts; Reversal of Anticoagulants and Anesthesia Considerations; Non-opioids Intravenous or Oral Analgesics for Perioperative Pain Management, Update; Uterotonic Medications and Anesthesia Considerations: oxytocin, misoprostol, methylergonovine, carboprost; Pulmonary Vascular Mediating Drugs, Evolving Concepts; Alpha 2 Modulators and Anesthesia Considerations; Pharmacologic Considerations of Anesthetic Agents in the Obese Patient; Pharmacologic Considerations of Anesthetic Agents in the Geriatric Patient; Pharmacologic Considerations of Anesthetic Agents in the Pediatric Patient; Anesthesia CV Drug Update; Pharmacogenomics: Anesthesia; Pharmacogenomics: Pain; Novel anticoagulants; Novel anesthetic agents; Novel opioids; Pharmacology of Newer Local anesthetics; Pharmacology of Nonsteroidal Antiinflammatory and Steroid Medications. Implications for Anesthesia or Unique Associated Risks; Pharmacology of Octreotide. Implications for Anesthesia and Associated Risks.